David Keeling

Biography

  David Keeling is Project Leader at Respiratory, Inflammation and Autoimmunity iMed, Gothenburg. He leads multi-disciplinary asthma research and development projects in pre-clinical and clinical phase. Two of these projects are international collaborations with pharmaceutical/biotech partners. From 2011 to 2013, he was Business Operations Director of RIA iMed and responsible for the smooth-running of the unit, comprising approximately 200 staff. In particular, this included orchestrating iMed governance through the RIA Research Board ensuring timely, high quality decision-making in support of project progression. Previously, David was Senior Project Manager at Respiratory and Inflammation Research Area (RIRA) AstraZeneca R&D, Charnwood, UK, from 2009 to 2011. During this time he was Chairperson/deputy of the Local Project Forum, bringing line managers, project leaders and senior scientists together to manage and support drug discovery projects. He was also member of the Research Area Portfolio Team (RAPT) responsible for implementing strategy and managing the size and shape of the RIRA discovery project portfolio. In 2014, David was made Director of Lead Generation Biology, a post he held for five years following his previous position as Associate Director. He line managed the Lead Generation Biology section of approximately 30 staff, and was jointly responsible for the delivery of lead series. From 1990 to 2001, David was a pre-clinical project leader within the Gastrointestinal, Cardiovascular Research Area at AstraZeneca, Mölndal, Sweden where he was responsible for establishing drug discovery projects in the novel area of osteoporosis and bone biology. A key area of focus was the osteoclast acid pump. David started his career within the pharmaceutical industry in the UK at SmithKline & French where he was involved as a biochemist in the drug discovery project leading to the gastric acid inhibitor, pantoprazole.

Research Interest

 Respiratory, Inflammation & Autoimmunity